Insider Transactions in Q1 2025 at Annexon, Inc. (ANNX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2025
|
Michael Overdorf EVP & CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
6,618
-7.1%
|
$13,236
$2.95 P/Share
|
|
Feb 18
2025
|
Ted Yednock EVP & CHIEF INNOVATION OFFICER |
SELL
Open market or private sale
|
Direct |
8,345
-11.99%
|
$16,690
$2.91 P/Share
|
|
Feb 18
2025
|
Dean Richard Artis EVP & CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
5,515
-6.17%
|
$11,030
$2.97 P/Share
|
|
Feb 18
2025
|
Jamie Dananberg CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,521
-14.16%
|
$11,042
$2.96 P/Share
|
|
Feb 18
2025
|
Jennifer Lew EVP & CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,912
-8.16%
|
$13,824
$2.92 P/Share
|
|
Feb 13
2025
|
Ted Yednock EVP & CHIEF INNOVATION OFFICER |
SELL
Open market or private sale
|
Direct |
1,783
-2.5%
|
$3,566
$2.99 P/Share
|
|
Feb 13
2025
|
Jennifer Lew EVP & CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,786
-2.07%
|
$3,572
$2.98 P/Share
|
|
Feb 13
2025
|
Michael Overdorf EVP & CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
1,425
-1.51%
|
$2,850
$2.99 P/Share
|
|
Feb 13
2025
|
Douglas Love PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
5,021
-1.41%
|
$10,042
$2.95 P/Share
|
|
Jan 06
2025
|
Douglas Love PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
37,994
+9.63%
|
$37,994
$1.41 P/Share
|